Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report

Gerritsen EJA, Vossen JM, Loo IHG van et al. Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course. Pediatrics 1994; 93: 247–253.

Frattini A, Orchard PJ, Sobacchi C et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis (Letter). Nat Genet 2000; 25: 343–346.

Sobacchi C, Frattini A, Orchard P et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet 2001; 10: 1767–1773.

Sly WS . The carbonic anhydrase II deficiency syndrome: osteopetrosis with renal tubular acidosis and cerebral calcifications. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Disease, vol. II, McGraw-Hill: New York, 2001, pp 5331–5343.

Kornak U, Kasper D, Bosl MR et al. Loss of the CIC-7 chloride channel leads to osteopetrosis in mice and man. Cell 2001; 104: 205–215.

Ballet JJ, Griscelli C, Coutris C et al. Bone-marrow transplantation in osteopetrosis. Lancet 1977; 2: 1137 (Letter).

Coccia PF, Krivit W, Cervenka J et al. Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med 1980; 302: 701–708.

Sorell M, Kapoor N, Kirkpatrick D et al. Marrow transplantation for juvenile osteopetrosis. Am J Med 1981; 70: 1280–1287.

Seiff CA, Chessels JM, Levinsky RJ et al. Allogeneic bone-marrow transplantation in infantile malignant osteopetrosis. Lancet 1983; 1: 437–441.

Gerritsen EJ, Vossen JM, Fasth A et al. Bone marrow transplantation for autosomal recessive osteopetrosis: a report from the working party on inborn errors of the European bone marrow transplantation group. J Pediatr 1994; 125: 896–902.

Key L, Carnes D, Cole S et al. Treatment of congenital osteopetrosis with high-dose calcitriol. N Engl J Med 1984; 310: 409–415.

Key LL, Rodriquiz RM, Willi SM et al. Long-term treatment of osteopetrosis with recombinant human interferon gamma. N Engl J Med 1995; 332: 1594–1599.

Reeves JD, Huffer WE, August CS et al. The hematopoietic effects of prednisone therapy in four infants with osteopetrosis. J Pediatr 1979; 94: 210–214.

Dorantes LM, Mejia AM, Dorantes S . Juvenile osteopetrosis: effects on blood and bone of prednisone and a low calcium, high phosphate diet. Arch Dis Child 1986; 61: 666–670.

Fischer A, Friedrich W, Fasth A et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report. Blood 1991; 77: 249–256.

Jabado N, Le Deist F, Cant A et al. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Pediatrics 1996; 98: 420–428.

Cobbold S, Martin G, Waldmann H . Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo. Transplantation 1986; 42: 239–247.

Locatelli F, Beluffi G, Georgiani G et al. Transplantation of cord blood progenitor cells can promote bone resorption in autosomal recessive osteopetrosis. Bone Marrow Transplant 1997; 20: 701–705.

Schulz AS, Classen CF, Mihatsch WA et al. HLA-haploidentical blood progenitor cell transplantation in osteopetrosis. Blood 2002; 99: 3458–3460.

Kaplan EL, Meier P . Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457–481.

Freeman JV, Cole TJ, Chinn S et al. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995; 73: 17–24.

Thompson DA, Kriss A, Taylor D et al. Early VEP and ERG evidence of visual dysfunction in autosomal recessive osteopetrosis. Neuropediatrics 1998; 29: 137–144.

Haines SJ, Erickson DL, Wirtschafer JD . Optic nerve decompression for osteopetrosis in early childhood. Neurosurgery 1988; 23: 470–475.

Rees H, Ang LC, Casey R, George DH . Association of infantile neuroaxonal dystrophy and osteopetrosis: a rare autosomal recessive disorder. Pediatr Neurosurg 1995; 22: 321–327.

Abinun M, Newson T, Rowe PW et al. Importance of neurological assessment before bone marrow transplantation for osteopetrosis. Arch Dis Child 1999; 80: 273–274.

Kapelushnik J, Shalev C, Yaniv I et al. Osteopetrosis: a single center experience of stem cell transplantation and prenatal diagnosis. Bone Marrow Transplant 2001; 27:129–132.

Flanagan AM, Sarma U, Steward CG et al. Study of the nonresorptive phenotype of the osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis. J Bone Miner Res 2000; 15: 352–360.

Helfrich MH, Gerritsen EJA . Formation of non-resorbing osteoclasts from peripheral blood mononuclear cells of patients with malignant juvenile osteopetrosis. Br J Hematol 2001; 112: 64–68.

Flanagan AM, Massey HM, Wilson C et al. Macrophage colony-stimulating factor and receptor activator NF-kappa B ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro. Bone 2002; 30: 85–90.

Marks SC . Osteopetrosis: multiple pathways for the interception of osteoclast function. Bone Pathology Appl Pathol 1987; 5: 172–183.

Teitelbaum SL . Bone resorption by osteoclasts. Science 2000; 289: 1504–1508.

Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990; 87: 4828–4832.

Droz-Desprez D, Azou C, Bordigoni P, Bonnaure-Mallet M . Infantile osteopetrosis: a case report on dental findings. J Oral Pathol Med 1992; 21: 422–425.

Jalevik B, Fasth A, Dahlof G . Dental development after successful treatment of infantile osteopetrosis with bone marrow transplantation. Bone Marrow Transplant 2002; 29: 537–540.